Practical Pharmacology For Alzheimer's Disease
by Takashi Kudo /
2016 / English / PDF
3.3 MB Download
In this book, the four leading experts on the ACE inhibitors
donepezil, galantamine, and rivastigmine and the NMDA receptor
antagonist memantine explain the practical pharmacology of these
symptomatic drugs with the aim of providing a sound basis for
their clinical use in patients with Alzheimer’s disease. In
addition, an introductory chapter considers the basic theory of
pharmacology for Alzheimer’s disease and the book closes with an
overview of the ways in which symptomatic drugs for dementia are
used.
In this book, the four leading experts on the ACE inhibitors
donepezil, galantamine, and rivastigmine and the NMDA receptor
antagonist memantine explain the practical pharmacology of these
symptomatic drugs with the aim of providing a sound basis for
their clinical use in patients with Alzheimer’s disease. In
addition, an introductory chapter considers the basic theory of
pharmacology for Alzheimer’s disease and the book closes with an
overview of the ways in which symptomatic drugs for dementia are
used.
The wide acceptance of the amyloid cascade hypothesis has led to
vigorous development of disease-modifying drugs for Alzheimer’s
disease, such as amyloid vaccinations and gamma- or
beta-secretase inhibitors. The failure of clinical trials of
these drugs to yield satisfactory results has, however, meant
that for the time being patients continue to be treated only with
symptomatic drugs. There is accordingly a need to become more
proficient in the use of symptomatic medicines, and it is against
the background of this quest that
The wide acceptance of the amyloid cascade hypothesis has led to
vigorous development of disease-modifying drugs for Alzheimer’s
disease, such as amyloid vaccinations and gamma- or
beta-secretase inhibitors. The failure of clinical trials of
these drugs to yield satisfactory results has, however, meant
that for the time being patients continue to be treated only with
symptomatic drugs. There is accordingly a need to become more
proficient in the use of symptomatic medicines, and it is against
the background of this quest thatPractical Pharmacology for
Alzheimer’s Disease
Practical Pharmacology for
Alzheimer’s Disease will be of wide interest.
will be of wide interest.
